NEU1, a key regulator of glycolysis, is markedly upregulated following DOX treatment. This upregulation is attributed to HIF1α’s transcriptional repression, requiring intricate interactions with NRF2. Increased NEU1 facilitates SIRT1 lysosomal degradation, contributing to aberrant glycolytic phenotype and cardiac damage.
Ting Gao+13 more
wiley +1 more source
Role of M2 macrophage-derived exosomes in cancer drug resistance via noncoding RNAs. [PDF]
Hu X, Li Y, Wang X, Xue X.
europepmc +1 more source
Rahul Shivahare Preeti Vishwakarma Venkateswarlu Korthikunta Tanvir Khaliq Tadigoppula Narender+1 more
openalex +1 more source
The efficacy and safety of chemoimmunotherapy in patients with MSI-L/MSS/pMMR status metastatic colorectal cancer: a systematic review and meta-analysis of randomized controlled trials. [PDF]
Zhang QJ+5 more
europepmc +1 more source
Dose-dense adjuvant chemotherapy for high-risk early breast cancer: its role in the era of personalised oncology. [PDF]
Savva C, Cutress R, Copson E.
europepmc +1 more source
The impact of cognitive behavioral therapy on disease uncertainty, stressful life events, quality of life, anxiety, and depression in glioma patients undergoing chemotherapy: a quasi-experimental study. [PDF]
Liu X+7 more
europepmc +1 more source
A novel perspective on dissemination: somatic metastasis of germ cell tumors from the central nervous system. [PDF]
Qi SP+10 more
europepmc +1 more source
NIR-responsive cisplatin nanoparticles for synergistic chemo-photothermal therapy of oral squamous cell carcinoma. [PDF]
Liu D+6 more
europepmc +1 more source
Related searches:
HOST CONDITIONING IN EXPERIMENTAL CHEMOTHERAPY*
Annals of the New York Academy of Sciences, 1958George W. Woolley+3 more
openaire +4 more sources